Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7324252 | 1.00 | ALDH1A1 (0.55) | ALDH1A1TSHRHPGDSIGMAR1L3MBTL1 | |
| SCHEMBL7289593 | 0.98 | ALDH1A1 (0.56) | ALDH1A1TSHRHPGDSIGMAR1L3MBTL1 | |
| SCHEMBL3028940 | 0.93 | ALDH1A1 (0.58) | ALDH1A1TSHRHPGDSIGMAR1L3MBTL1 | |
| SCHEMBL1802353 | 0.85 | ALDH1A1 (0.62) | ALDH1A1TSHRHPGDSIGMAR1L3MBTL1 | |
| SCHEMBL8576604 | 0.82 | ALDH1A1 (0.59) | ALDH1A1TSHRHPGDSIGMAR1L3MBTL1 | |
| SCHEMBL6398343 | 0.82 | ALDH1A1 (0.55) | ALDH1A1TSHRHPGDSIGMAR1MAPT | |
| SCHEMBL6686635 | 0.82 | ALDH1A1 (0.55) | ALDH1A1TSHRHPGDSIGMAR1MAPT | |
| SCHEMBL10401024 | 0.82 | ALDH1A1 (0.55) | ALDH1A1TSHRHPGDSIGMAR1L3MBTL1 | |
| SCHEMBL29350218 | 0.82 | ALDH1A1 (0.55) | ALDH1A1TSHRHPGDSIGMAR1MAPT | |
| SCHEMBL1170746 | 0.82 | ALDH1A1 (0.55) | ALDH1A1TSHRHPGDSIGMAR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114034687-B | Method and device for high-precision detection of calcium ions | 中国科学院烟台海岸带研究所 | 2023-12-29 | — | — | CN | disclosed |
| US-20230304959-A1 | SOLID STATE SOIL SENSOR | PLANT BIOSCIENCE LIMITED (GB) | 2023-09-28 | — | — | US | disclosed |
| CN-109557162-A | Sensing device and ion detection method | 王玉麟 | 2019-04-02 | — | — | CN | disclosed |
| EP-2344661-B1 | METHODS FOR DETECTING DIHYDROTESTOSTERONE BY MASS SPECTROMETRY | QUEST DIAGNOSTICS INVEST INC (US) | 2019-02-20 | — | — | EP | disclosed |
| EP-2659501-B1 | QUANTITATION OF INSULIN BY MASS SPECTROMETRY | QUEST DIAGNOSTICS INVEST INC (US) | 2017-09-06 | — | — | EP | disclosed |
| EP-3124617-A1 | METHODS FOR DETECTING DIHYDROTESTOSTERONE BY MASS SPECTROMETRY | Quest Diagnostics Investments Incorporated (US) | 2017-02-01 | — | — | EP | disclosed |
| US-20090028802-A1 | ORGANOLEPTICALLY ACCEPTABLE INDOLE SEROTONIN RECEPTOR AGONIST ORAL DOSAGE FORMULATIONS AND METHODS OF USING THE SAME | TEIKOKU PHARMA USA, INC. | 2009-01-29 | — | — | US | disclosed |
| US-6200444-B1 | Cation-selective sensor | INSTITUT FUER CHEMO UND BIOSENSORIK MUENSTER E.V. (DE) | 2001-03-13 | — | — | US | disclosed |
| US-4670218-A | HOMOGENEOUS HYDROPHOBIC SUBSTANCE, IONOPHORE CAPABLE OF COMPL EXING WITH THE ION REPORTER SUBSTANCE | MILES LABORATORIES, INC. (US) | 1987-06-02 | — | — | US | disclosed |
| US-4645744-A | FORMING COMPLEX WITH IONOPHORE ON CARRIER MATRIX | MILES LABORATORIES, INC. (US) | 1987-02-24 | — | — | US | disclosed |
| US-4504368-A | ELECTRODES, CROWN ETHER | EASTMAN KODAK COMPANY (US) | 1985-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090028802-A1 | ORGANOLEPTICALLY ACCEPTABLE INDOLE SEROTONIN RECEPTOR AGONIST ORAL DOSAGE FORMULATIONS AND METHODS OF USING THE SAME | HTR5A, HTR3A, HTR1A | ALDH1A1 1081/4885TSHR 207/4885HPGD 2028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.